MENU
+Compare
LUCD
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$1.03
Change
-$0.01 (-0.96%)
Capitalization
104.95M

LUCD Lucid Diagnostics Forecast, Technical & Fundamental Analysis

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma... Show more

LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LUCD with price predictions
Sep 26, 2025

LUCD in +3.88% Uptrend, advancing for three consecutive days on September 16, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LUCD advanced for three days, in of 201 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on LUCD as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 107 cases where LUCD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LUCD moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for LUCD turned negative on September 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at .

LUCD moved below its 50-day moving average on September 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LUCD crossed bearishly below the 50-day moving average on September 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUCD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LUCD broke above its upper Bollinger Band on August 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (60.117). P/E Ratio (0.000) is within average values for comparable stocks, (36.948). LUCD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.680). LUCD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (16.340) is also within normal values, averaging (79.117).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LUCD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUCD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LUCD is expected to report earnings to rise 2.50% to -10 cents per share on November 17

Lucid Diagnostics LUCD Stock Earnings Reports
Q3'25
Est.
$-0.10
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.01
The last earnings report on August 13 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 582.19K shares outstanding, the current market capitalization sits at 104.95M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
360 Madison Avenue
Phone
+1 917 813-1828
Employees
70
Web
https://www.luciddx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LQWDF1.250.11
+9.65%
LQWD TECHNOLOGIES CORP.
XLMDF0.03N/A
N/A
XLMEDIA PLC
ANSLF20.02N/A
N/A
Ansell Ltd.
KRYAF103.12N/A
N/A
Kerry Group plc
DYNDF5.22-0.18
-3.41%
DYE & DURHAM LTD.

LUCD and Stocks

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-0.96%
NOTV - LUCD
32%
Poorly correlated
+1.47%
FEMY - LUCD
31%
Poorly correlated
+4.29%
CRL - LUCD
26%
Poorly correlated
+2.05%
PAVM - LUCD
25%
Poorly correlated
-1.26%
NTRA - LUCD
23%
Poorly correlated
-0.42%
More

Groups containing LUCD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-0.96%
Medical/Nursing Services
industry (226 stocks)
22%
Poorly correlated
-0.24%
Health Services
industry (437 stocks)
16%
Poorly correlated
+0.41%